Insider Transactions in Q1 2021 at Navidea Biopharmaceuticals, Inc. (NAVB)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2021
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
21,500
+31.39%
|
$43,000
$2.07 P/Share
|
|
Mar 03
2021
|
Malcolm G Witter Director |
BUY
Open market or private purchase
|
Direct |
15,000
+37.04%
|
$30,000
$2.31 P/Share
|
|
Jan 13
2021
|
Claudine Bruck Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+16.61%
|
-
|
|
Jan 13
2021
|
Adam D. Cutler Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+20.0%
|
-
|
|
Jan 13
2021
|
Yehuda Michael Rice Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+16.67%
|
-
|
|
Jan 13
2021
|
Sarah Kathryn Rouan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+15.77%
|
-
|
|
Jan 13
2021
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+16.13%
|
-
|